General
Preferred name
CARTEOLOL HYDROCHLORIDE
Synonyms
OPC-1085 hydrochloride ()
Carteolol HCl ()
Arteoptic ()
Mikelan ()
Abbott-43326 ()
Carteolol hydrochloride,OPC-1085 hydrochloride ()
OPC-1085 ()
Ocupress ()
Teoptic ()
Cartrol ()
NSC-300906 ()
Carteolol (hydrochloride) ()
P&D ID
PD010674
CAS
51781-21-6
Tags
natural product
drug
available
Drug Status
approved
Max Phase
Phase 4
Drug indication
Anti-Adrenergic (beta-receptor)
First approval
1988
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
8
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
MedChem Express Bioactive Compound Library
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
19
Properties
(calculated by RDKit )
Molecular Weight
328.16
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
3
Rotatable Bonds
5
Ring Count
2
Aromatic Ring Count
1
cLogP
2.12
TPSA
70.59
Fraction CSP3
0.56
Chiral centers
1.0
Largest ring
6.0
QED
0.77
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
GPCR/G protein
Neuronal Signaling
Target
??-adrenergic receptor
Adrenergic Receptor
Source data
